Galectin-3 Antibody (M3/38) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-43553
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Flow Cytometry
Label
Biotin
Antibody Source
Monoclonal Rat IgG2a Kappa Clone # M3/38
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen for this antibody was Galectin3 Mac2.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2a Kappa
Scientific Data Images for Galectin-3 Antibody (M3/38) [Biotin]
Flow Cytometry: Galectin-3 Antibody (M3/38) [Biotin] [NBP1-43553] - Intracellular staining of the monocyte population in normal human peripheral blood cells (right) or C57BL/6 mouse bone marrow cells (left) with Anti-Mouse CD11b APC and 0.125 ug of Anti-Human/Mouse Galectin-3 Biotin followed by Streptavidin PE. Total viable cells were used for analysis.
Applications for Galectin-3 Antibody (M3/38) [Biotin]
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Application Notes
This M3/38 antibody has been tested by flow cytometric analysis of mouse PECs (thioglycollated elicied peritioneal cells). This can be used at less than or equal to 0.25 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8cells/test.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.2) with 0.1% gelatin
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Galectin-3
Alternate Names
AGE-R3, CBP35, GAL3, Galectin3, L29, LGALS3, Mac-2
Gene Symbol
LGALS3
Additional Galectin-3 Products
Product Documents for Galectin-3 Antibody (M3/38) [Biotin]
Product Specific Notices for Galectin-3 Antibody (M3/38) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...